Diabetes and obesity

Obesity

Type 2 diabetes

Obesity

Obesity and diabetes: lipids, ‘nowhere to run to’

M. J. Hill, D. Metcalfe and P. G. McTernan

Published on the Internet 15 December 2008, doi:10.1042/CS20080050

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF

Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine

G. Sommer, A. Garten, S. Petzold, A. G. Beck-Sickinger, M. Blüher, M. Stumvoll and M. Fasshauer.........13–23

Published on the Internet 2 June 2008, doi:10.1042/CS20070226

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF

Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases

H. Tilg and A. R. Moschen

Published on the Internet 15 January 2008, doi:10.1042/CS20070196

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF

Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome

H. Bugger and E. D. Abel

Published on the Internet 10 January 2008, doi:10.1042/CS20070166

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF

Alterations in plasma and tissue lipids associated with obesity and metabolic syndrome

C. M. Aguilera, M. Gil-Campos, R. Cañete and Á. Gil

Published on the Internet 10 January 2008, doi:10.1042/CS20070115

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF

Type 2 diabetes

Cellular and physiological effects of C-peptide

C. E. Hills and N. J. Brunskill

Published on the Internet 2 March 2009, doi:10.1042/CS20080441

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF

Pathogenic perspectives for the role of inflammation in diabetic nephropathy

A. Rivero, C. Mora, M. Muros, J. García, H. Herrera and J. F. Navarro-González

Published on the Internet 12 February 2009, doi:10.1042/CS20080394

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF

Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes

W. Jin and M.-E. Patti

Published on the Internet 15 December 2008, doi:10.1042/CS20080090

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF

Role of PPARγ in renoprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential

J. Yang, D. Zhang, J. Li, X. Zhang, F. Fan and Y. Guan

Published on the Internet 28 November 2008, doi:10.1042/CS20070462

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF

Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes

M. Buraczynska, A. Swatowski, K. Buraczynska, M. Dragan and A. Ksiazek

Published as Immediate Publication 30 May 2008, doi:10.1042/CS20070411

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF

Dynamic cerebral autoregulatory capacity is affected early in Type 2 diabetes

Y.-S. Kim, R. V. Immink, W. J. Stok, J. M. Karemaker, N. H. Secher and J. J. van Lieshout

Published as Immediate Publication 18 March 2008; doi:10.1042/CS20070458

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF

Postprandial paradoxical IGFBP-1 response in obese patients with Type 2 diabetes

M. Lehtihet, S. Efendic and K. Brismar

Published as Immediate Publication 22 January 2008, doi:10.1042/CS20070372

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF

Long-term hyperglucagonaemia induces early metabolic and renal phenotypes of Type 2 diabetes in mice

X. C. Li, T.-d. Liao and J. L. Zhuo

Published as Immediate Publication 20 November 2007, doi:10.1042/CS20070257

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Commentary

Glucagon and hyperglycaemia in diabetes

P. E. Cryer (see accompanying paper pp. 591–601)

Published as Immediate Publication 15 January 2008, doi:10.1042/CS20070434

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper

Plasma proteome changes in subjects with Type 2 diabetes mellitus with a low or high early insulin response

T. Sundsten, B. Zethelius, C. Berne and P. Bergsten

Published as Immediate Publication 26 October 2007, doi:10.1042/CS20070323

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF

Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with Type 2 diabetes

P. M. Srivastava, P. Calafiore, R. J. MacIsaac, S. K. Patel, M. C. Thomas, G. Jerums and L. M. Burrell

Published as Immediate Publication 5 October 2007, doi:10.1042/CS20070261

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF